EcoDrugPlus

Ensembl ID : ENSOMYG00000003267
Gene Symbol: -
Cross references: -
148 Possible Orthologues:

Ensembl ID : ENSOMYG00000020182
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSOMYG00000020189
Gene Symbol: -
Cross references: -
144 Possible Orthologues:

Ensembl ID : ENSOMYG00000002896
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSOMYG00000020357
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSOMYG00000002871
Gene Symbol: -
Cross references: -
633 Possible Orthologues:

Ensembl ID : ENSOMYG00000002119
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSOMYG00000020810
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSOMYG00000002674
Gene Symbol: -
Cross references: -
244 Possible Orthologues:

Ensembl ID : ENSOMYG00000002655
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSOMYG00000002649
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSOMYG00000002239
Gene Symbol: -
Cross references: -
220 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).